HIV drugs
London activists push Gilead to lower price of new HIV drug

Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir

Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug

The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma